在外教育施設派遣教員安全対策資料 在外教育施設派遣教員安全対策資料

Similar documents
JOMF-キッズネットQ&Aブック

加藤茂孝先生

-51-

フィナレビ106号.indb

idwr2008_21

(Travel Medicine) (Emerging Re-emerging Diseases) ) ) ) ) ) ) ) 10 ) 12 ) ) 12 ) 13 ) 14 ) 15 ) 17 ) 18 ) 20 ) 22 24

諸外国における妊娠・出産等に関する情報提供事例収集 2

13●53頁●6-7▲院内感染対策▲.ppt

SARS %,

:,, : - 7 -

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

Microsoft Word - 講演録.docx


untitled

untitled

ISBN ISBN 5 128p ISBN ISBN 2

民事責任規定・エンフォースメント

496


ISBN ISBN 0 0 ISBN

ISBN ISBN ISBN


idwr2015_24

untitled

加藤茂孝先生

DNA

EMS EMS W264

スライド 1


座談会/2009

橡アロマセラピー症状別処方例.PDF

Cover_Page.qxd

,195, ,025, ,634, ( )


熱中症-2.PDF

Summary



小児感染免疫第29巻第2号

退職互助だより_cs6.indd


8

受益証券発行信託受益権の 株式等振替制度対応に関する説明会

SARS HIV/AIDS n = 672; % 5% 2% 8% 16% 43% 20%

24回日本エイズ学会誌1_ indd

01

untitled

Microsoft Word - 表紙資料2-4

食事編_表1_4_0508

untitled




1965( 40) * 1969( 44) 1996( 8) 5 * 1995( 7) ( 9) ( 8) ( 12)

日医雑誌第126巻第9号

Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS BPD CHD 50mg100mg RS20138 RS Respiratory Syncytial Virus RS

地域と文化資産


NETWORKER s s 2 UNICEF CHILDREN'S NET NEWS No.6


無印良品のスキンケア

Q 23 A Q Q15 76 Q23 77

1 Copyright 2009 INFOCOM CORPORATION All rights reserved.

FDI2 22 BRICs 22 ODA 22 PF SSA FDI International Finance Corporation 29

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

MM0506-Ariyoshi.ind

1.4操作マニュアル+ユニット解説

0.3% 10% 4% 0.8% 5% 5% 23% 53%

1


untitled

西食堂


フィジカルコンディショニング

PowerPoint プレゼンテーション

支援リスト3/30.xls

第5回東京都廃棄物審議会

untitled

橡82-93協力員原稿>授業

17. (1) 18. (1) 19. (1) 20. (1) 21. (1) (3) 22. (1) (3) 23. (1) (3) (1) (3) 25. (1) (3) 26. (1) 27. (1) (3) 28. (1) 29. (1) 2

ジェネリック医薬品販売会社(田辺製薬販売株式会社)の設立に伴う包装変更のご案内


06地図目録.pwd

REPORT



BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

UX-V503CL/UX-V503CW

第3章 焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点

4 13 STEP- 3 12

ほんぶん-第6章.indd




野岩鉄道の旅

表紙_02

VOL. 21 NO. 2 CHEMOTHERAPY 395

評価結果報告書の概要版(平成20年度)

sick contact1l

金沢医科大学報第116号

Transcription:

1. 1. 1.1.1. 1.1.2. 1.1.3. 1.1.4. 1.1.5. 1. 2. 1. 3. 1. 4. 1-1 1-2 1-3 2. 1. 2. 2. 2. 3. 2. 4. 2.4.1. 2.4.2. 2-1 2. 5. 2. 6. 2.6.1. 2.6.2. 2.6.3. 2.6.4. 2.6.5. 2. 7. 2.7.1.

2.7.2. 2.7.3. 2.7.4. 2. 8. 2. 9. 2-2 3. 1. 3-1 3.1.1. 3-1 3.1.2. 3.1.3. 3. 2. 3.2.1. 3.2.2. 3.2.3. 3.2.4. 3.2.5. 3. 3. 3.3.1. 3.3.2. 3.3.3. 3.3.4. 3.3.5. 3. 4. 3. 5. 3. 6. 3-2 3. 7. 3-3 3-4

4. 1. 4.1.1. 4.1.2. 4.1.3. 4.1.4. 4.1.5. 4.1.6. 4.1.7. 4. 2. 4.2.1. 4.2.2. 4.2.3. 4. 3. 4. 4. 4. 5. 4.5.1. 4.5.2. 4.5.3. 4.5.4. 4. 6. 4.6.1. 4.6.2. 4.6.3. 4.6.4. 4. 7. 4. 8. 4. 9. 4-1 5. 1. 5-1 5-2

5. 2. 5-3 5.2.1. 5-4 5. 3. 5-5 5.3.1. 5-6ORS 5.3.2. 5.3.3. 5.3.4. 5.3.5. 5.3.6. 5.3.7. 5. 4. ARI 5-7 5. 5. 5-8 5.5.1. 5.5.2. 5.5.3. 5.5.4. 5. 6. 5-9 5-10 5. 7. 5.7.1. 5.7.2. 5.7.3. 6. 1. 6. 2. 6. 3. 6. 4.

6. 5. 6. 6. 6. 7. 6. 8. 6. 9. SARS 7. 1. SARS 7. 2. SARS 7. 3. SARS 7. 4. SARS 7. 5. SARS 7.5.1. 7.5.2. 7.5.3.SARS 7.5.4.SARS 8. 1. 8. 2. 8. 3. 8.3.1. BCG 8.3.2. 8.3.3.DPT 8.3.4. 8.3.5. 8.3.6. 8.3.7. 8.3.8. 8.3.9. Hib 8. 4. 8.4.1. 8.4.2. BCG 8.4.3. 8.4.4.

8.4.5. 8.4.6. 8.4.7. 8.4.8. 8.4.9. 8.4.10. 8. 5. 8.5.1. 8.5.2. 8.5.3. 8.5.4. 8.5.5. 8.5.6. 8.5.7. 8.5.8. 8.5.9. 8.5.10. 8. 6. 8-1 8-2 8-3 8-4 8-5 9. 1. 9. 2. 9. 3. Emerging/Re-emerging Infectious Diseases 9. 4. 9. 5. 9. 6. 9.6.1. 9.6.2. 9.6.3. 9. 7.

9.7.1. 9.7.2. 9.7.3. 9.7.4. 9. 8. 9. 9. 9. 10. 9-1 1973 9-2 20 9-3 10. 1. 10.1.1 10-1 10.1.2. 10.1.3. 10. 2. 10-1 10.2.1. 10.2.2. 10.2.3. 10-2 10. 3. 10.3.1. 10-3 10.3.2. 10. 4. 10.4.1. 10.4.2. 10-4 10.4.3. (1)

(2) (3) (4)

1 1. 1. 1.1.1. X 1.1.2.

2 1.1.3. 1.1.4. 1.1.5.

3 1. 2. X 1. 3.

4 1. 4.

5

6

7 2. 1. 2. 2.

8 BCG DPT BCG WHO BCG 1957

9 Hib 2. 3. (2)

10 2. 4. 2.4.1.

11 2.4.2. 2. 5.

12 2. 6. 2.6.1.

13 2.6.2. 2.6.3.

14 2.6.4. 2.6.5.

15 2. 7. 2.7.1. 200 300 2.7.2. 2.7.3.

2.7.4. 2. 8. 2. 9. 16

17

3. 1. 18

19 3.1.1. 3.1.1.1. 3.1.1.2.

20 3.1.1.3. 3.1.1.4. 3.1.2. 3.1.3.

21 3. 2. 3.2.1. 3.2.2. General Practitioner Family Medicine Internal Medicine Pediatrics 3.2.3.

22 3.2.4. 3.2.5. 3. 3. 3.3.1. 3.3.2.

23 3.3.3. 3.3.4. 3.3.5. 3. 4.

24 3. 5. 3. 6.

25 3. 7.

26

27 PTSD 4. 1. 4.1.1. 4.1.2.

28 4.1.3. 4.1.4. 4.1.5. 4.1.6. 4.1.7. 4. 2. 4.2.1.

4.2.2. 4.2.3. 4. 3. 1981 WHO 1981 1983 29

1984-5 4. 4. 1985 1995 683 683 197 486 2,47 244 198 144 100 66 23 18 613 108 90 30

31 4. 5. 4.5.1. 4.5.2. 4.5.3. 4.5.4. HIV/AIDS

4. 6. 4.6.1. 4.6.2. 4.6.3. 32

4.6.4. 4. 7. 33

34 4. 8. 4. 9. SARS PTSD

PTSD PTSD 1. 1997 2. 1998 35

36 SARS 5. 1.

37 O-157 (3) 5. 2.

38 5.2.1.

39 1

5. 3. Oral Rehydration Therapy 5.3.1. 1940 WHO UNICEF 1975 Oral Rehydration Salts/Solution, ORS ORS ORS OS-1 40

ORS ORS Na (mmol/l) K (mmol/l) (g/l) ORS (WHO) 60-90 20 20 OS-1 50 20 25 21 5 58-66 2 0.1 50-150 5.3.2. 5.3.3. 5.3.4. ORS 41

42 5.3.5. 5.3.6. 5.3.7. 5. 4. ARI Acute Respiratory Infection, ARI

5. 5. 5.5.1. 50 90 5.5.2. 43

44 5.5.3. 5.5.4. 2002 7 1955 5. 6.

45

46

47 5. 7. 5.7.1.

5.7.2. 5.7.3. 1937 1990 1999 2002 44 4,156 284 2003 1 48

1. No.4027, p1-7. 2001 2. Travel Health Onlinehttp://www.tripprep.com 3. CDC: http://www.cdc.gov/travel/ 4. http:www.forth.go.jp/ 5. http://idsc.nih.go.jp/index-j.html 6. 1999 3 31 7. 1998 3 25 8. Modern Physician 14 11 1994 11 15 9. Red Book 2003, 26 th ed.american Academy of Pediatrics 10. 2003 2 28 49

50 6 HIV/AIDS 6. 1. WHO

1993 6. 2. (Plasmodium falciparum) (P. vivax) (P. malariae) (P. ovale) 48 72 51

52 90 37 6. 3. DIC

53 6. 4.

54 6. 5. 10 50 1960 WHO WHO 28 72

25mg 500mg Stevens-Johnson 1 qinghaosu G6PD 55

56 6. 6.

57 100 300 300 200 250 250 6. 7.

58 2 6. 8. 6. 9.

59

SARS 2002 2003 SARS Knowledge dispels fear 7. 1. SARS SARS Severe Acute Respiratory Syndrome 2002 11 SARS 7. 2. SARS SARS SARS SARS SARS SARS 60

SARS SARS 2004 SARS SARS SARS Basic Reproductive rate; R 1218 7. 3. SARS 210 5 70 80 20 ARDS 10 050 SARS 12 SARS 7. 4. SARS 61

CT SARS APTT LDH SARS PCR SARS SARS 7. 5. SARS Isolation Contact Tracing Quarantine SARS 2002 62

2003 7.5.1. SARS WHO SARS WHO WHO Global Epidemic Surveillance SARS WHO WHO SARS http://www.who.int/csr/sars/en/index.html http://www.who.int/csr/don/en/ WHO http://idsc.nih.go.jp/index-j.html http://www.mhlw.go.jp/ (3) 7.5.2. SARS SARS SARS Respiratory etiquette SARS 63

7.5.3.SARS SARS SARS SARS 10 10 SARS 10 7.5.4.SARS SARS 7080 SARS SARS Personal Protective EquipmentPPE 64

65 8. 1. 1990 WHO UNICEF EPIExpanded Programme on Immunization BCG DPT

80 1996 8. 2. 8. 3. 8.3.1. BCG 200 800 700 BCG 66

BCG BCG BCG BCG 8.3.2. WHO UNICEF 1,919 2002 WHO 2003 1991 1997 DPT 67

8.3.3.DPT 1990 DPT Hib DPT DT DPT 1970 DPT 1981 DPT DPT 8.3.4. 68

MMR MMR MMR Jeryl-Lynn MMR 1975 MMR MMR MMR 1989 AIK-C TO336 Am9 933 1993 4 MMR MMR MMR 8.3.5. 40 69

WHO 1995 8.3.6. 1995 16 8.3.7. WHO International Health Regulation 70

WHO 2003 15 WHO2003 10 10 8.3.8. 10 1989 8.3.9. Hib 71

Hib 1990 8. 4. 8.4.1. WHO 8.4.2. BCG BCG BCG 8.4.3. 72

73 8.4.4. 10 8.4.5. MMR 8.4.6. 8.4.7. 8.4.8. 2050 1995 8.4.9. MMR

8.4.10. MMR 8. 5. 8.5.1. WHO 8.5.2. DPT DT 1968 DPT 12 DT 10 10 8.5.3. 60 74

8.5.4. Ty21a V 80 8.5.5. 8.5.6. 8.5.7. 8.5.8. 8.5.9. 75

76 8.5.10. 8. 6. FORTH http://www.forth.go.jp/ 2,000 http://jpa.umin.jp/index.htm/ (3) WHO 1994 2004

BCG DPT B Hib * **Hib HibDPTHibDPT HibDPT 77

12-18 6-12 6-12 10 12-18 12-18 6-12 1-2 1-4 12 2 12-18 7 28 2-3 18 6 3-6 6-12 Hib 6-12 3-5 International Travel and Health (WHO,Geneva,1999) 1997 Red Book, American Academy of Pediatrics p5 Hib HibDPTHibDPT HibDPT 78

(*) (*) 79

80

9. 1. 100 1999 15 2003 9. 2. communicable disease infectious disease 81

9. 3. Emerging/Re-emerging Infectious Diseases 1995 WHO emerging and re-emerging infectious diseases emerging infectious disease re-emerging infectious diseases 9. 4. 100 82

83 9.5. 9.5. 1 9. 5. (1999 )

(2001 ) (2003 ) WHO Global Alert (SARS: Severe Acute Respiratory Syndrome) 2003 11 9. 6. SARS 9.6.1. SARS 9.6.2. 84

85 9.6.3. 9. 7. SARS 9.7.1. 9.7.2.

86 9.7.3. 9.7.4. 9. 8. SARS SARS A VRSA

RS 2004 9. 9. SARS SARS WHO 87

9. 10. 3,000 600 900 3000 2000 5,000 500 (CD-ROM ) (http://idsc.nih.go.jp/index-j.html) (Infectious Disease Weekly Report: IDWR) SARS IDWR (http://idsc.nih.go.jp/index-j.html) IDWR PDF 88

HTML CD-ROM 89

90

91

92

2003 11 SARS E A Q B E A AIDS/HIV RS A 93

94

95 10. 1. 10.1.1.

96 10.1.2. 10.1.3. 10.1.3.1. 10.1.3.2. 10.1.3.3. 10. 2.

97

98 10.2.1. 15 10.2.2.

10.2.3. 1 1 A A B C 1-2 3-5 7-14 99

100 10 14 1 10. 3. 10.3.1. 10.3.1.1. 10.3.1.2.

101 N95 dust-mist:dm dust-fume-mist:dfm 10.3.1.3. 0.050.1 0.050.2 70 5ml

102 0.020.05 30 10.3.2. 10. 4.

10.4.1. 10.4.2. 103

10.4.3. 104

(1) 5 320 ISBN4-87402-496-32,940 398 ISBN4-8185-2315-12,730 2004 3 105

4 410 ISBN4-7890-0793-61,835 479 ISBN4-478-03415-X1,840 243 ISBN4-87402-080-12,400 2002 30 123 210 ISBN4-83270-209-21,785 30 250-350 2,447 NIS 23 106

230 1,600 43 (2) 135 ISBN4-8795-4072-21,529 909 ISBN4-2632-3422-7 2,100 2003 1269 ISBN4-3911-2922-96,090 2003 107

1,672 ISBN4-8327-0360-94,095 2000 321 ISBN4-7890-07272,039 257 ISBN4-7890-067191,835 108

320 3,150 2 2 ( A5 52 787 2 (3) (JICA) http://www.jica.go.jp/ninkoku/index.html 20 ODA 1997 2003 109

110 http://www.anzen.mofa.go.jp/index.html http://www.mofa.go.jp/mofaj/toko/medi/index.html 83 (JOHAC) http://www3.johac.rofuku.go.jp/ FAX (JOMF) http://www.jomf.or.jp/ SARS JOMF- http://www.forth.go.jp/

http://idsc.nih.go.jp/vaccine/vaccine-j.html http://malaria.himeji-du.ac.jp/ipublic/malaria-net-j/home.html WHO International Travel and Health 2001 Travel Health Online https://www.tripprep.com/ Shoreland, Inc. 1996 CDC Travelers Health http://www.cdc.gov/travel/ CDC Diseases 111

Traveling with children WHO International travel and health http://www.who.int/ith/ WHO 2004 4 http://www.mcfh.co.jp/ FAX http://www.j-poison-ic.or.jp/homepage.nsf 75 http://www.crn.or.jp/index.html 112

http://mmh.banyu.co.jp/ http://www.iiha-jda.com/guide/index.html 130 http://www.health-net.or.jp/index.html (4) JOHAC http://www.johac.rofuku.go.jp/ 113

114 FAX http://www.johac.rofuku.go.jp/inquiry/faxformat.pdf JOHAC +81-45-474-6098 JOHAC http://www.johac.rofuku.go.jp/ 2004 7 5

http://www.forth.go.jp/ T-PORT +81-3-5223-3527 1-5-1 +81-476-34-2310 1-1 +81-45-474-6001 3211 JOHAC JCB +81-3-5352-8286 JCB 24 115

JCB JCB 1 24 JCB 16 JCB 24 +1-800-596-7641 +81-3-5352-8286 116

SARS